Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001080877 | SCV000290084 | likely benign | Alstrom syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000225835 | SCV000535489 | likely benign | not provided | 2020-12-30 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000439387 | SCV000859129 | likely benign | not specified | 2018-01-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000225835 | SCV001152350 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | ALMS1: BP4, BP7 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000439387 | SCV002572378 | likely benign | not specified | 2022-08-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002356302 | SCV002621847 | likely benign | Cardiovascular phenotype | 2019-01-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV000439387 | SCV001924452 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000439387 | SCV001927524 | benign | not specified | no assertion criteria provided | clinical testing |